Cargando…
Collagen-based scaffolds with infused anti-VEGF release system as potential cornea substitute for high-risk keratoplasty: A preliminary in vitro evaluation
Currently the only widely accepted corneal blindness treatment is human donor cornea transplantation. However, increasing shortage of donor corneas as well as high risk of rejection in some corneal diseases remain two major problems, which limit the success of corneal transplantation. Corneal neovas...
Autores principales: | Buznyk, Oleksiy, Azharuddin, Mohammad, Islam, Mohammad M., Fagerholm, Per, Pasyechnikova, Nataliya, Patra, Hirak K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533359/ https://www.ncbi.nlm.nih.gov/pubmed/33033763 http://dx.doi.org/10.1016/j.heliyon.2020.e05105 |
Ejemplares similares
-
Bioengineered Corneas Grafted as Alternatives to Human Donor Corneas in Three High‐Risk Patients
por: Buznyk, Oleksiy, et al.
Publicado: (2015) -
Collagen-Based Bioengineered Substitutes of Donor Corneal Allograft Implantation: Assessment and Hypotheses
por: Pasyechnikova, Nataliya, et al.
Publicado: (2012) -
Biomaterials-enabled cornea regeneration in patients at high risk for rejection of donor tissue transplantation
por: Islam, M. Mirazul, et al.
Publicado: (2018) -
Phosphorylcholine and KR12-Containing Corneal Implants in HSV-1-Infected Rabbit Corneas
por: Malhotra, Kamal, et al.
Publicado: (2023) -
LiQD Cornea: Pro-regeneration collagen mimetics as patches and alternatives to corneal transplantation
por: McTiernan, Christopher D., et al.
Publicado: (2020)